Algernon Receives Clearance from Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial

VANCOUVER, British Columbia, April 29, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.…

Algernon Receives Regulatory and Ethics Approval for Phase 2 Ifenprodil COVID-19 Human Study in South Korea

VANCOUVER, British Columbia, April 23, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.…

Top Penny Stocks To Watch This Week; 1 Up 116% In April 2020

Will These Names Be On Your List Of Penny Stocks To Watch…

Algernon Announces Regulatory Submission for Ifenprodil COVID-19 Human Trial in South Korea

VANCOUVER, British Columbia, April 09, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.…

Algernon Announces Positive Feedback from Health Canada for Ifenprodil COVID-19 Phase 2 Human Trial

VANCOUVER, British Columbia, April 08, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.…